BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11364010)

  • 1. Responding to CMV neurologic infections.
    Smart T
    GMHC Treat Issues; 1996 Nov; 10(11):5-7, 10. PubMed ID: 11364010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum and treatment of cytomegalovirus disease in persons with AIDS.
    Spector SA
    J Int Assoc Physicians AIDS Care; 1996 May; 2(5):9-12, 15-22. PubMed ID: 11363539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of AIDS-related cytomegalovirus disease with ganciclovir and foscarnet association. Three case reports.
    Manfredi R; Mastroianni A; Coronado OV; Chiodo F
    Recenti Prog Med; 1996 Nov; 87(11):545-8. PubMed ID: 9122537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ganciclovir implants: one year later.
    Cadman J
    GMHC Treat Issues; 1997; 11(4/5):3-6. PubMed ID: 11364375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of cytomegalovirus infection in patients with acquired immunodeficiency syndrome.
    Pau AK; Pitrak DL
    Clin Pharm; 1990 Aug; 9(8):613-31. PubMed ID: 2167189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraocular therapy for cytomegalovirus retinitis.
    Palestine AG
    J Int Assoc Physicians AIDS Care; 1996 May; 2(5):25-8. PubMed ID: 11363527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of cytomegalovirus esophagitis in patients with acquired immune deficiency syndrome: a randomized controlled study of foscarnet versus ganciclovir. The Italian Cytomegalovirus Study Group.
    Parente F; Bianchi Porro G
    Am J Gastroenterol; 1998 Mar; 93(3):317-22. PubMed ID: 9517631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 5. Clinical features of cytomegalovirus retinitis at diagnosis. Studies of ocular complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group.
    Am J Ophthalmol; 1997 Aug; 124(2):141-57. PubMed ID: 9262538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A brighter future for the AIDS patient.
    Lowell E; Van Tassell B
    Insight; 2002; 27(4):95-6. PubMed ID: 12520982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between foscarnet exposure, baseline cytomegalovirus (CMV) blood culture and the time to progression of CMV retinitis in HIV-positive patients.
    Drusano GL; Aweeka F; Gambertoglio J; Jacobson M; Polis M; Lane HC; Eaton C; Martin-Munley S
    AIDS; 1996 Sep; 10(10):1113-9. PubMed ID: 8874628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ganciclovir therapy for cytomegalovirus (CMV) infection of the central nervous system in AIDS patients: monitoring by CMV DNA detection in cerebrospinal fluid.
    Cinque P; Baldanti F; Vago L; Terreni MR; Lillo F; Furione M; Castagna A; Monforte AD; Lazzarin A; Linde A
    J Infect Dis; 1995 Jun; 171(6):1603-6. PubMed ID: 7769299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome.
    Reddy AJ; Zaas AK; Hanson KE; Palmer SM
    J Heart Lung Transplant; 2007 Dec; 26(12):1286-92. PubMed ID: 18096480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elucidation of cytomegalovirus disease recurrence in an HIV-1-positive patient.
    Kottaridi C; Ploumidis G; Grapsas E; Feretis C; Benakis P; Filalithis P; Bouzarelou D; Nasioulas G
    J Gastroenterol; 2003; 38(7):643-6. PubMed ID: 12898356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protease inhibitors linked to drop in CMV retinitis.
    AIDS Alert; 1997 Aug; 12(8):92-4. PubMed ID: 11364475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to combined ganciclovir and foscarnet therapy in a liver transplant recipient with possible dual-strain cytomegalovirus coinfection.
    Rodriguez J; Casper K; Smallwood G; Stieber A; Fasola C; Lehneman J; Heffron T
    Liver Transpl; 2007 Oct; 13(10):1396-400. PubMed ID: 17902124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytomegalovirus disease in patients with acquired immunodeficiency syndrome. Report of 63 cases].
    Martínez Lacasa JT; Podzamczer D; Rufí G; Bolao F; Pérez JL; Gudiol F
    Med Clin (Barc); 1993 Jan; 100(2):41-5. PubMed ID: 8381498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemically proven cytomegalovirus end-organ disease in solid organ transplant patients: clinical features and usefulness of conventional diagnostic tests.
    Fica A; Cervera C; Pérez N; Marcos MA; Ramírez J; Linares L; Soto G; Navasa M; Cofan F; Ricart MJ; Pérez-Villa F; Pumarola T; Moreno A
    Transpl Infect Dis; 2007 Sep; 9(3):203-10. PubMed ID: 17511827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination antiviral therapy for ganciclovir-resistant cytomegalovirus infection in solid-organ transplant recipients.
    Mylonakis E; Kallas WM; Fishman JA
    Clin Infect Dis; 2002 May; 34(10):1337-41. PubMed ID: 11981729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy improves CMV treatment.
    AIDS Alert; 1996 Mar; 11(3):32-3. PubMed ID: 11363244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is combination antiviral therapy for CMV superior to monotherapy?
    Drew WL
    J Clin Virol; 2006 Apr; 35(4):485-8. PubMed ID: 16387546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.